Catalyst Inc. Closes the Market

Catalyst Inc. is holding the Catalyst Convene Canada event on October 21, 2026. The event is designed to emphasize exceptional Canadian business leaders who are implementing real, systemic change and workplace inclusion for women. Jennifer McCollum, President and Chief Executive Officer of Catalyst Inc., and Julie Vaux, Executive Director in Canada, participated in a market closing ceremony with Cristina Caldaroni, Senior Manager, Investigative Services, TMX Group, and Women's Resource Group Leadership Team member. Catalyst Convene Canada, formerly known as Catalyst Honours, is a one-day hybrid event that brings together Canada's business, HR, and inclusion leaders. The theme for this year's event is 'Illuminate', focusing on how inclusive leadership can help organizations navigate complexity, unlock performance, and accelerate progress for women at work. The event aims to highlight ideas, strategies, and actions that challenge assumptions and help organizations shape more innovative, high-performing, and equitable workplaces. Catalyst Inc. is described as a global nonprofit recognized for its expertise in women's advancement and inclusion since the 1960s. The organization accelerates organizational performance and women's progress through research-backed insights, high-impact convenings, proven solutions, and support. The event will feature Canada's brightest minds and is intended to fuel the next wave of progress for women at work. The market closing ceremony was held to celebrate the upcoming Catalyst Convene Canada event. The event is positioned as a platform for sharing best practices and driving systemic change in workplace inclusion for women. The announcement highlights Catalyst's ongoing commitment to making inclusion a business practice at scale.

Health Catalyst Reports Second Quarter 2026 Results

(NASDAQ: HCAT) Health Catalyst, Inc. reported financial results for the quarter ended June 30, 2026, with total revenue of $70,487,000 and a net loss of $40,537,000. The company exceeded the high end of its revenue guidance and the midpoint of its adjusted EBITDA guidance for the second quarter. Gross profit for the quarter was $27,856,000, with a gross margin of 40%, and adjusted EBITDA was $9,919,000. Health Catalyst recently closed the Vitalware divestiture and fully repaid its credit facility debt. For the third quarter of 2026, the company expects total revenue of $55 million to $56 million and adjusted EBITDA of $0 to $0.5 million. For the full year 2026, Health Catalyst expects total revenue of $246 million to $249 million and adjusted EBITDA of $18 million to $18.5 million. As of June 30, 2026, cash and cash equivalents were $60,589,000, and total assets were $358,604,000.